NCT02083991View on ClinicalTrials.gov

Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2017

Study Completion Date

December 31, 2017

Conditions
Diabetes Mellitus
Interventions
DRUG

Steroid-free low TAC-arm: Thymoglobulin Standard low-TAC arm: Simulect, prednisolon

Trial Locations (1)

41345

Transplant Institute, Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
lead

Vastra Gotaland Region

OTHER_GOV

NCT02083991 - Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation | Biotech Hunter | Biotech Hunter